All articles
Wegovy® Pill vs. Injection: Differences & Which Is Right for You?
Reading time:
9 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
Side Effects: Wegovy Pill vs. Injection
Because they include the same active ingredient, the side-effect profile is largely the same for both medications. The most common effects are gastrointestinal (nausea, vomiting, diarrhea, constipation, and abdominal pain), and they're most likely during dose escalation, easing for many people as the body adjusts. Our guide on GLP-1 side effects: what's normal and what's not covers how to manage them.
The main difference is mechanical: injection-site reactions (redness, itching, a small bump) can happen with the pen, and simply don't exist with the pill. In OASIS 4, serious adverse events were reported in 3.9% of the semaglutide group versus 8.8% of the placebo group, meaning serious events were not more common with the drug than placebo in that trial.
Both forms carry the same important warnings, and these apply regardless of which you choose. Semaglutide carries a boxed warning for thyroid C-cell tumors and is contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). It's also not appropriate for people with a history of pancreatitis in some cases, can raise the risk of gallbladder problems, and should not be used during pregnancy. If any of that might apply to you, read who should not take Wegovy and talk it through with a provider before starting.
Wegovy Pill vs. Injection Cost
Price is where a lot of people land, and the honest picture depends heavily on insurance.
Self-pay (through NovoCare): As of mid-2026, the Wegovy pill is priced from about $149/month at the 1.5 mg and 4 mg doses, though the 4 mg offer runs through August 31, 2026, then moves to $199/month. The injection starts around $199/month for new patients at lower doses, with the high-dose 7.2 mg pen priced higher (around $399/month). So at some doses the pill is the cheaper self-pay option, but not universally.
With commercial insurance: If your plan covers Wegovy, a savings program can bring your copay down to as little as ~$25/month for either form.
Medicare: Starting July 2026, Medicare covers GLP-1s for weight management, with copays around $50/month for eligible enrollees. See Medicare GLP-1 coverage in 2026 for the details.
One caveat: prices, promotions, and coverage rules change often. Always check current NovoCare pricing and your own insurance formulary before deciding based on cost alone.
Can You Switch Between the Pill and the Injection?
Yes, and it's simpler than most people expect. Switching from the shot to the pill typically involves taking your last injection, waiting 7 days, and then starting the pill. If you're at the 2.4 mg weekly maintenance dose, your provider may have you move straight to the 25 mg pill with no re-titration. Any change to your medication regimen should be done with provider guidance.
The reverse works the same way: your last pill counts toward the 7-day spacing before your next injection, per label guidance. And here's a detail almost no one mentions: if the 25 mg pill isn't well tolerated, ask your provider whether switching to the 1.7 mg pen makes sense rather than pushing through it on your own.
Why do this with a provider rather than on your own? Timing matters, side effects can flare briefly around a change, and a good provider helps you switch without losing the momentum you've built. This is exactly the kind of adjustment providers who work with Mochi manage routinely, with follow-up along the way.
Which One Is Right for You?
There's no universal winner here, just a better fit for your situation. A rough framework:
You may lean toward the pill if needles are your main barrier to starting or staying on treatment, and your mornings are consistent enough to protect a 30-minute empty-stomach window every day.
You may lean toward the injection if you want once-a-week simplicity, you value having the most-studied maximum weight-loss data behind you, or you're not willing to give up your morning coffee, breakfast, or other morning medications for half an hour daily.
Then there are the practical factors: travel and refrigeration (the pen needs some planning; the pill doesn't), whether you'd rather swallow a tablet or use a pen, dose flexibility, and the quirks of your specific insurance formulary. Both are legitimate, evidence-backed options. This is a conversation worth having with a provider who can weigh your health profile against your day-to-day life.
The Bottom Line
It’s the same active ingredient, just delivered in two different ways. On trial averages, the injection edged slightly ahead, but those studies weren't head-to-head, and averages don't tell you which one you'll actually stick with. The best option is often the one that you'll actually take consistently, whether that's a weekly shot you rarely think about or a daily pill that fits neatly into a steady morning routine.
If you're weighing the two, you don't have to guess. Providers who work with Mochi may prescribe both the Wegovy pill and injection, help you choose based on your routine and coverage, and can manage a switch in either direction, with ongoing monitoring through unlimited follow-up visits. Check your eligibility to talk through which form of semaglutide fits your health, your schedule, and your budget.
FAQs
Is the Wegovy pill FDA-approved?
Yes. The FDA approved the oral Wegovy pill on December 22, 2025 as the first oral GLP-1 for chronic weight management in adults. It launched in the U.S. in January 2026.
Is the Wegovy pill as effective as the injection?
In separate trials, the injection produced about 14.9% average weight loss (STEP 1) and the 25 mg pill produced 13.6–16.6% (OASIS 4). Because these weren't head-to-head studies, the numbers can't be read as one form beating the other, and individual results vary. Both produce substantial, clinically meaningful weight loss.
Can I switch from the Wegovy shot to the pill?
Often, yes. After you take your last injection, you may be able to start taking the pill starting from day 8. Your provider will guide you through the specifics of the transition, including your starting dose.
Why does the Wegovy pill have to be taken on an empty stomach?
Because approximately 1–2% of oral semaglutide is absorbed. Food, other liquids, and other oral medications in your stomach reduce that further. Taking it first thing in the morning with no more than 4 oz of water, then waiting 30 minutes, gives the drug its best chance to work.
Is the Wegovy pill the same as Rybelsus?
No, though both include semaglutide as their active ingredient, Rybelsus is FDA-approved for type 2 diabetes at 3, 7, and 14 mg. The Wegovy pill is approved for chronic weight management at a much higher 25 mg dose.
Disclaimer: This article is for educational purposes only and should not be considered medical advice. The information provided does not constitute recommendations for treatment. Always consult with your healthcare provider about your specific situation, symptoms, and treatment options. Individual results are not guaranteed and may vary from person to person. Prescription medications require a written prescription from a licensed provider.
Share this post
Weight loss
More articles














